High-Content & Phenotypic Screening 2018 is part of the event organisers, Innovations in Drug Discovery 2018 Conference to be held in Cambridge, UK.
This conference held co-located and concurrently with Stem Cells in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 explores the emerging trends and technologies impacting Drug Discovery, circa 2018.
The conference content and presentations are intertwined and delegates and exhibitors receive full access to both tracks.
This conference brings together researchers from both academia and industry, and will discuss the development of techniques and tools implemented in High-Content technologies and Phenotypic Screening applications.
Topics to be covered include 3D-cell based screening methods, high content screening and data management, the use of model organisms and novel approaches for phenotypic screening.
Attending this event will provide you with excellent opportunities for networking with attendees from big pharmaceutical and biotech companies, academia and technology/tools vendors, helping you to find solutions and build collaborations.
*Please note: events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged.
Professor, University of Edinburgh
Professor, Department of Physics and Photonics Group, Imperial College London
Chief Drug Development Scientist, Cancer Research UK
Full Professor and Director, Technische Universität Braunschweig
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford
Research Fellow, Abbvie
Senior Investigator, Novartis Institutes for BioMedical Research
Confirmed Speakers to Date
UK Team Leader, Cisbio Bioassays
Professor, Dublin Institute of Technology
Research Scientist, UCB
Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star
PhD Student, University of Melbourne
Assistant Professor, University of Nottingham
Cellular Imaging Application Specialist, GE Life Sciences
Finnish Distinguished Professor, Fellow FIMM Helsinki and Group Leader, Hungarian Academia of Sciences
Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)
Hua Rong Lu
Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV
Head of Clinical Pathology, University College Dublin
Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia
BHF Senior Research Fellow, University of Cambridge
Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
E. Sally Ward
Professor, Texas A&M University Health Science Center
Senior Scientist, CYTOO SA